• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

TABLE 8Biochemical recurrence within 12 months

StudyRobotic, n/N (%)Laparoscopic, n/N (%)Open, n/N (%)
Artibani 200312312/63 (19.0)5/44 (11.4)
Krambeck 200910814/248 (5.6)32/492 (6.5)
Lama 20091336/56 (10.7%)7/59 (11.9)
Ou 20091136/30 (20.0)5/30 (16.7)
Poulakis 200713717/204 (8.3)11/70 (15.7)
Schroeck 200811529/362 (8.0)54/435 (12.4)
Predicted probability of event0.0870.0970.110
OR (95% CrI); probability outcome favours robotic prostatectomyAll studies0.89 (0.24 to 3.34); 0.588
Low-risk studies onlyNot estimable

From: 4, Clinical effectiveness of robotic compared with laparoscopic techniques

Cover of Systematic Review and Economic Modelling of the Relative Clinical Benefit and Cost-Effectiveness of Laparoscopic Surgery and Robotic Surgery for Removal of the Prostate in Men with Localised Prostate Cancer
Systematic Review and Economic Modelling of the Relative Clinical Benefit and Cost-Effectiveness of Laparoscopic Surgery and Robotic Surgery for Removal of the Prostate in Men with Localised Prostate Cancer.
Health Technology Assessment, No. 16.41.
Ramsay C, Pickard R, Robertson C, et al.
© 2012, Crown Copyright.

Included under terms of UK Non-commercial Government License.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.